Log in

International Society for antiviral research

Abstract Submission DETAILS

Abstracts are no longer being accepted for ICAR2024.

Important Abstract Deadlines

  • December 1, 2023:  Abstract submission site opens
  • January 8, 2024:  Submission deadline to receive early visa notifications 
  • January 29, 2024 at 11:59 PM ET:  Submission deadline for oral presentations, TCFF scholarships, travel assistance and the PechaKucha Competition 
  • February 1, 2024:  Site opens for submissions to be considered for poster presentations only and poster awards
  • February 29, 2024:  Abstract acceptance notifications sent (for all abstracts submitted by January 26 deadline). 
  • March 20, 2024:  Accepted authors confirm acceptance and presentation plans
  • March 22, 2024:  Submission deadline for poster presentations only
  • April 1, 2024:  Late-Breaking Abstract Submission Site Opens (orals and posters; not eligible for awards)
  • April 5, 2024:  Second abstract acceptance notifications sent (for all abstracts submitted by March 22 deadline)
  • April 12, 2024:  Registration deadline for all accepted presenters
  • April 15, 2024:  Submission deadline for Late-Breaking Abstracts (orals and posters; not eligible for awards)
  • April 26, 2024:  Deadline for presenters to upload their bios, photos and/or electronic posters

Late-Breaking Abstracts

A limited number of oral and poster presentations will be reserved for abstracts containing the most recent data with cutting edge implications and impact. Submit your abstract now through the online submission system.

  • A late-breaking abstract submission for an oral or poster should contain late-breaking, high quality research for which no preliminary data were available at the time of the prior abstract submission deadlines. The research must be new and of sufficient scientific importance to merit special consideration after the standard abstract deadlines.
  • Abstracts that have already been accepted for ICAR2024 are not eligible for consideration.
  • Late-breaking abstracts cannot be a revision of an abstract submitted prior to the submission deadline.
  • Late-breaking abstracts are not eligible to participate in the PechaKucha or Poster Awards competitions.

About the ICAR2024 Program

In-person and virtual programming options will be available for ICAR2024 .  The onsite meeting in Gold Coast, Australia will include oral and poster sessions, plenary talks, ISAR awardee lectures and several special sessions and networking events.  The oral sessions will be recorded and available to all registered attendees on the virtual platform for on-demand viewing.  All accepted posters will be available via the virtual platform with online Q&A chat boards to promote discussion. All on-demand content will be available through July 31, 2024.  

View Schedule-at-a-Glance

Abstract Details 

We welcome short oral presentations and posters describing the activity of well-defined chemical compounds for the treatment of viral diseases of humans and vertebrate animals and on the protective activity of vaccines for humans.  Reports of the antiviral effect of a novel small-molecule drug are encouraged to include chemical structures, as long as such reporting does not negatively impact the potential development of novel antivirals.  Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis.  We discourage the submission of abstracts reporting the antiviral activity of unpurified natural products, or of partially purified substances.  Abstracts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will be rejected.  Presentations on antiseptics with broad-spectrum antimicrobial activity will not be considered.  We also discourage talks or posters on silicodocking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays.

Submission tracks:

    Presentation Formats

    • SHORT ORAL PRESENTATIONS - Authors who elect to be considered for an oral presentation must plan to present onsite in Gold Coast, Australia.  Should your abstract be selected for an oral presentation, you will be requested to confirm your in-person presentation plans no later than March 20, 2024.  

    • POSTER PRESENTATIONS - Authors have the option to present in a poster session onsite in Gold Coast, Australia or present a virtual-only poster.  If you are attending the conference in Gold Coast, it is expected that you will present your poster in-person AND upload a virtual poster.  Upon receiving your abstract acceptance notification, you will be requested to confirm your attendance plans (onsite or virtual) no later than March 20, 2024.  All accepted poster presenters (onsite and virtual) will be required to submit their virtual posters no later than April 26, 2024 

    What is the difference between a virtual poster and onsite poster?

    Abstract Submission Process

    • When logging into the abstract site, you must log-in as the presenter.  Submission link will be posted on December 1st.
    • Abstracts must be submitted online and will not be accepted in any other manner. 
    • Abstract title is limited to 250 characters.  Abstract body is limited to 1700 characters to include spacing. The system will automatically impose these restrictions when you enter your abstract.

    • During the submission process you will be able to indicate your interest in participating in the Poster Awards Competition, PechaKucha Competition and Travel Awards.

    • Oral presentations will be selected only from the initial submission period, which ends on January 29th. The site will reopen on February 1st and remain open through March 22nd, but acceptance during this period will only be for poster presentations. Poster submissions during this time are still eligible to compete for the Poster Awards (indicate interest during the submission process). 
    • To be considered for an oral presentation, the PechaKucha Competition or a Travel Award, you MUST submit an abstract by the January 29th deadline.  
    • If you need to apply for a visa and need early notification, you MUST submit an abstract by January 8th.  Abstracts submitted after January 8th will be sent notifications on February 29th. 

      Poster Awards Competition Submission Details 

      A regular feature of ICAR is the judging of posters by a designated committee and the award of cash prizes.  For your poster to be entered in the competition, you must indicate your interest during the abstract submission process, following the instructions below: 

      1. Login to the submission site to start your abstract submission. 
      2. When asked if you would like to be considered for a Poster Award, select "Yes”. 
      3. Answer the subsequent questions. 
      4. Further details will be provided after abstract acceptance notifications have been sent. Please note that you will be required to submit an electronic poster by April 26, 2024. 
      5. Anyone who is selected for an oral presentation, but would like to also compete for a Poster Award, should notify ICAR Staff and prepare a poster to present at the meeting.  

      About ISAR

      The International Society for Antiviral Research (ISAR) is an internationally recognized organization for scientists involved in basic, applied, and clinical aspects of antiviral research. The Society main event is the annual International Conference on Antiviral Research (ICAR), a truly interdisciplinary meeting which attracts the interest of chemists, biologists, and clinicians.



      Powered by Wild Apricot Membership Software